Effects of Long-Term Pioglitazone Treatment on Peripheral and Central Markers of Aging
Eric M. Blalock, Jeremiah T. Phelps, Tristano Pancani et al. · 2010
Read Effects of Long-Term Pioglitazone Treatment on Peripheral and Central Markers of Aging by Eric M. Blalock, Jeremiah T. Phelps, Tristano Pancani et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010405.txt.
Description
Eric Blalock and co-workers tracked aging markers in mice given a diabetes drug long-term, for PLOS ONE in 2010. Pioglitazone helps restore insulin response in type 2 diabetes. It works through a master switch for fat and sugar handling. Reports had suggested such drugs might also slow brain aging in Alzheimer's models. The team measured aging signs in both body and brain after long treatment.
Long use lets benefits and harms both show up honestly. The study read out many markers rather than one, giving a broad picture. Drugs taken for years by millions deserve that kind of checking. Results here inform debates about repurposing diabetes drugs for brain protection. Aging, the authors remind us, is a whole-body process worth measuring widely.
Catalog record
| CREATOR | Eric M. Blalock, Jeremiah T. Phelps, Tristano Pancani et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 82 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010405